[1] 文飞球,刘四喜.儿童血小板增多症[J].中华实用儿科临床杂志,2013,28(15):1124-1125. DOI:10.3760/cma.j.issn.2095-428X.2013.15.002.
[2] 中华医学会儿科学分会呼吸学组,«中华儿科杂志»编辑委员会.儿童社区获得性肺炎管理指南(2013修订)(上)[J].中华儿科杂志,2013,51(10):745-752. DOI:10.3760/cma.j.issn.0578-1310.2013.10.006.
[3] Chiarello P, Magnolia M, Rubino M, et al. Thrombocytosis in children[J]. Minerva Pediatr, 2011, 63(6):507-513.
[4] Cheminant M, Delarue R. Investigation and management of patients presenting with thrombocytosis[J]. Rev Med Interne, 2013, 34(8):465-471. DOI: 10.1016/j.revmed. 2013.02.020.
[5] Kanikarla Marie P, Fowlkes NW, Afshar-Kharghan V, et al. The provocative roles of platelets in liver disease and cancer[J]. Front Oncol, 2021, 11:643815. DOI: 10.3389/fonc.2021.643815.
[6] Varon D, Shai E. Platelets and their microparticles as key players in pathophysiological responses[J]. J Thromb Haemost, 2015, 13 Suppl 1:S40-S46. DOI: 10.1111/jth.12976.
[7] Carestia A, Godin LC, Jenne CN. Step up to the platelet: role of platelets in inflammation and infection[J]. Thromb Res, 2022:S0049-3848(22)00411-X. DOI: 10.1016/j.thromres.2022.10.001.
[8] Thomas MR, Storey RF. The role of platelets in inflammation[J]. Thromb Haemost, 2015, 114(3):449-458. DOI: 10.1160/TH14-12-1067.
[9] Rondina MT, Garraud O. Emerging evidence for platelets as immune and inflammatory effector cells[J]. Front Immunol, 2014, 5:653. DOI: 10.3389/fimmu.2014.00653.
[10] 任晓旭.重症腺病毒感染对血液系统的损伤[J].中国小儿急救医学,2019,26(10):729-733. DOI:10.3760/cma.j.issn.1673-4912.2019.10.003.
[11] 国家呼吸系统疾病临床医学研究中心,中华医学会儿科学分会呼吸学组,中国医师协会呼吸医师分会儿科呼吸工作委员会,等.儿童呼吸道合胞病毒感染诊断、治疗和预防专家共识[J].中华实用儿科临床杂志,2020,35(4):241-250. DOI:10.3760/cma.j.cn101070-20200225-00243.
[12] 中华医学会儿科学分会呼吸学组,«中华实用儿科临床杂志»编辑委员会.儿童肺炎支原体肺炎诊治专家共识(2015年版)[J].中华实用儿科临床杂志,2015,30(17):1304-1308. DOI:10.3760/cma.j.issn.2095- 428X.2015.17.006.
[13] 李琳霞,赵琳,李艳红,等.新生儿感染性肺炎血小板参数的动态变化[J].中国新生儿科杂志,2010,25(3):172-173. DOI:10.3969/j.issn.1673-6710.2010.03.017.
[14] 廖景文.肺炎婴儿危重病例评分与血小板数量关系探讨[J].中国中西医结合儿科学,2015,7(6):572-574. DOI:10.3969/j.issn.1674-3865.2015.06.013.
[15] 张向峰,常会娟,张小宁,等.小儿支气管肺炎伴血小板增多的临床特征及炎症因子的变化情况分析[J].中国实用医刊,2017,44(7):90-92. DOI:10.3760/cma.j.issn.1674-4756. 2017.07.029.
[16] 刘蕾,许婉华,周丽霞,等.血小板生成素水平在急性炎症状态的变化及其意义探讨[J].中国实验血液学杂志,2017,25(3):860-865. DOI:10.7534/j.issn.1009-2137.2017. 03.041.
[17] Xiang M, Wu X, Jing H, et al. The impact of platelets on pulmonary microcirculation throughout COVID-19 and its persistent activating factors[J]. Front Immunol, 2022, 13:955654. DOI: 10.3389/fimmu.2022.955654.
[18] Granja TF, Köhler D, Leiss V, et al. Platelets and the cybernetic regulation of ischemic inflammatory responses through PNC formation regulated by extracellular nucleotide metabolism and signaling[J]. Cells, 2022, 11(19):3009. DOI: 10.3390/cells11193009.
[19] Yadav P, Beura SK, Panigrahi AR, et al. Platelet-derived microvesicles activate human platelets via intracellular calcium mediated reactive oxygen species release[J]. Blood Cells Mol Dis, 2023, 98:102701. DOI: 10.1016/j.bcmd.2022.102701.
[20] Marr N, Wang TI, Kam SH, et al. Attenuation of respiratory syncytial virus-induced and RIG-I-dependent type I IFN responses in human neonates and very young children[J]. J Immunol, 2014, 192(3):948-957. DOI: 10.4049/jimmunol.1302007.
|